CNR Institutional Research Information System

DI MARZO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 17.206
NA - Nord America 8.475
SA - Sud America 3.385
EU - Europa 3.366
AF - Africa 310
Continente sconosciuto - Info sul continente non disponibili 268
OC - Oceania 19
AN - Antartide 1
Totale 33.030
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.900
SG - Singapore 7.417
CN - Cina 3.444
BR - Brasile 2.626
HK - Hong Kong 2.020
VN - Vietnam 1.606
IT - Italia 1.198
FR - Francia 1.008
KR - Corea 682
BD - Bangladesh 478
JP - Giappone 420
IN - India 269
CA - Canada 224
NL - Olanda 224
AR - Argentina 215
GB - Regno Unito 190
CO - Colombia 166
DE - Germania 156
ID - Indonesia 153
FI - Finlandia 149
EC - Ecuador 139
MX - Messico 128
IL - Israele 103
ZA - Sudafrica 86
VE - Venezuela 80
TR - Turchia 78
IQ - Iraq 74
PK - Pakistan 71
UA - Ucraina 68
SA - Arabia Saudita 66
ES - Italia 55
JM - Giamaica 50
MY - Malesia 49
RU - Federazione Russa 47
CL - Cile 42
CR - Costa Rica 42
MA - Marocco 41
PY - Paraguay 41
PH - Filippine 40
UZ - Uzbekistan 39
AT - Austria 37
PE - Perù 37
EG - Egitto 34
PL - Polonia 34
KE - Kenya 27
TH - Thailandia 26
UY - Uruguay 25
TN - Tunisia 24
TT - Trinidad e Tobago 24
SC - Seychelles 22
SE - Svezia 22
AZ - Azerbaigian 20
DZ - Algeria 20
NI - Nicaragua 20
IE - Irlanda 19
HN - Honduras 18
JO - Giordania 17
AE - Emirati Arabi Uniti 16
NP - Nepal 16
BG - Bulgaria 15
GT - Guatemala 14
AU - Australia 13
SV - El Salvador 13
DO - Repubblica Dominicana 12
RS - Serbia 12
BE - Belgio 11
RO - Romania 10
SN - Senegal 10
TW - Taiwan 10
AL - Albania 9
BO - Bolivia 9
HU - Ungheria 9
KZ - Kazakistan 9
PT - Portogallo 9
BH - Bahrain 8
BY - Bielorussia 8
DK - Danimarca 8
LB - Libano 8
PA - Panama 8
PR - Porto Rico 8
BB - Barbados 7
CZ - Repubblica Ceca 7
EE - Estonia 7
GR - Grecia 7
LT - Lituania 7
OM - Oman 7
AM - Armenia 6
GE - Georgia 6
MD - Moldavia 6
NG - Nigeria 6
QA - Qatar 6
BA - Bosnia-Erzegovina 5
CH - Svizzera 5
CY - Cipro 5
ET - Etiopia 5
GA - Gabon 5
KG - Kirghizistan 5
LA - Repubblica Popolare Democratica del Laos 5
MM - Myanmar 5
NZ - Nuova Zelanda 5
Totale 32.672
Salva come PNG Salva come JPEG
Città #
Singapore 4.420
Hong Kong 1.987
Hefei 1.604
Santa Clara 1.274
San Jose 969
Lauterbourg 836
Ashburn 692
Seoul 666
Ho Chi Minh City 593
Beijing 517
Hanoi 376
Tokyo 307
Los Angeles 275
Dallas 206
New York 193
São Paulo 185
Rome 149
Naples 144
Council Bluffs 140
Milan 110
Buffalo 93
Minamishinagawa 92
Helsinki 87
Rio de Janeiro 86
Da Nang 84
Brasília 78
Phoenix 63
Chicago 62
Haiphong 62
Guangzhou 59
Houston 58
Bengaluru 57
Atlanta 52
Brooklyn 50
Dhaka 50
Lappeenranta 50
Philadelphia 49
Curitiba 47
Frankfurt am Main 47
Belo Horizonte 46
Quito 46
Nuremberg 40
Biên Hòa 39
Bogotá 39
Guayaquil 38
Newark 38
Las Vegas 37
Toronto 37
Campinas 35
Guarulhos 35
Johannesburg 34
Orem 34
Porto Alegre 34
Tashkent 34
Afragola 32
San José 32
Boardman 30
Baghdad 29
Mexico City 29
Shanghai 29
Kingston 28
Salvador 28
London 27
Charlotte 26
Elk Grove Village 26
Miami 26
Queens 26
Chennai 25
Detroit 25
Istanbul 25
Montreal 25
Warsaw 25
Florence 24
Lima 24
Asunción 23
Kuala Lumpur 23
Nairobi 23
Shenzhen 23
The Bronx 23
Cleveland 22
Columbus 22
Hải Dương 22
Buenos Aires 21
Casandrino 21
Cincinnati 21
Fortaleza 21
Jeddah 21
Medellín 21
Osasco 21
Thái Bình 21
Washington 21
Amsterdam 20
Cairo 20
Jakarta 20
Orlando 20
Bắc Ninh 19
Caracas 19
Goiânia 19
Managua 19
Ribeirão Preto 19
Totale 18.521
Salva come PNG Salva come JPEG
Nome #
2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors 129
Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. 106
Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice 105
y The time course of erythrocyte membrane fatty acid concentrations during and after treatment of non-human primates with increasing doses of an omega-3 rich phospholipid preparation derived from krill-oil 105
First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury 101
Short and efficient synthesis of alkylresorcinols: a route for the preparation of cannabinoids 96
Orexin-A and endocannabinoids are involved in obesity-associated alteration of hippocampal neurogenesis, plasticity, and episodic memory in mice 96
Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis 90
Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors 89
N-Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth 88
Oral Ultramicronized Palmitoylethanolamide:Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect 87
Cannabinoids and the expanded endocannabinoid system in neurological disorders 85
The short-chain fatty acid acetate modulates orexin/hypocretin neurons: A novel mechanism in gut-brain axis regulation of energy homeostasis and feeding 83
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome 83
The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity 82
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 82
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity 82
Synthesis of 18F-labeled nitrogen heterocyclic derivatives as new candidate for cannabinoid CB2 receptor PET imaging 80
Olive oil-derived endocannabinoid-like mediators inhibit palatable food-induced reward and obesity 80
Palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1. 80
Interactions of non-THC phytocannabinoids and Cannabis extracts with TRP channels and endocannabinoid metabolic enzymes 79
Bisphenol A Induces Fatty Liver by an Endocannabinoid-Mediated Positive Feedback Loop 79
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret 79
Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI 78
Orexin-A Prevents Lipopolysaccharide-Induced Neuroinflammation at the Level of the Intestinal Barrier 77
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. 77
N-palmitoyl-d-glucosamine, a natural monosaccharide-based glycolipid, inhibits tlr4 and prevents lps-induced inflammation and neuropathic pain in mice 77
Human gut microbiota and their production of endocannabinoid-like mediators are directly affected by a dietary oil 77
A sustainable protocol for the synthesis of N-acyl tryptamines, a class of potential gut microbiota-derived endocannabinoid-like mediators 76
Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington?s disease 76
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson s disease 75
Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis 75
Lipidic secondary metabolites as endogenous regulators or pharmacological tools in Hydrozoan development 74
Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists. 73
Anandamide: Endocannabinoid, endovanilloid, or both? 73
Endocannabinoid chemical biology: a tool for the development of novel therapies 73
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity 73
Biosynthesis of the novel endogenous 15-lipoxygenase metabolites N-13-hydroxy-octodecadienoyl-ethanolamine and 13-hydroxy-octodecadienoyl-glycerol by human neutrophils and Eosinophils 73
Anticipatory and consummatory effects of (hedonic) chocolate intake are associated with increased circulating levels of the orexigenic peptide ghrelin and endocannabinoids in obese adults 73
Endocannabinoid-based drugs with multiple sites of action: riding several horses against inflammation and hyper-reactivity 72
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 72
Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis 72
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus. 71
Pharmacological preparation for topical use containing npalmitoyl-vanillamide 71
Enantioselective synthesis of 1-(R)-hydroxypolygodial and its 9 Ñ epimer, 1-(R)-hydroxyisotadeonal 71
Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain 71
Cannabinoids 70
Early endocannabinoid-mediated depolarization-induced suppression of excitation delays the appearance of the epileptic phenotype in synapsin II knockout mice 70
Validation of a fast and sensitive UPLC-MS/MS quantitative method for N-acyl taurine analysis in biological samples 70
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. 69
COMPARATIVE ANALYSIS OF ENDOCANNABINOID SYSTEM GENE EXPRESSION ON METASTATIC VS PRIMITIVE MELANOMA CELL LINES. 69
The cannabimimetic eicosanoid, anandamide, regulated rat brain protein kinase C and mouse macrophage arachidonate release 68
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy. 68
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy 68
Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis 68
In silico identification and experimental validation of (-)-muqubilin A, a marine norterpene peroxide, as PPARalpha/gamma-RXRalpha agonist and RARalpha positive allosteric modulator 68
Synthesis and molecular targets of N-13-hydroxy-octadienoyl-ethanolamine, a novel endogenous bioactive 15-lipoxygenase-derived metabolite of N-linoleoyl-ethanolamine found in the skin and saliva 68
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 67
Altered endocannabinoid signalling after a high-fat diet in Apoe (-/-) mice:relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance 67
CB1, but not CB2, mediates stimulation of bone formation induced by traumatic brain injury. 66
The gut microbiome, endocannabinoids and metabolic disorders. 66
Prostamide F2a receptor antagonists with inhibitory activity at FAAH: a way to prevent the confounding effects of pro-inflammatory mediators formed following selective FAAH inhibition? 66
Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential 66
Pharmacological preparation for topical use containing n-palmitoyl-vanillamide 65
Targeted Lipidomics Investigation of N-acylethanolamines in a Transgenic Mouse Model of AD: A Longitudinal Study 65
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity (vol 55, pg 1799, 2016) 64
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent. 64
Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1 64
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations 64
Enantiospecific synthesis of bioactive hydroxyeicosatetraenoic acids (HETEs) in Hydra magnipapillata. 63
Phytocannabinoids in the treatment of cancer 63
Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes 63
Acute Kappa opioid receptor blocking disrupts the pro-cognitive effect of cannabidiol in neuropathic rats 63
Enhanced Visualization of Endocannabinoids Spatial Distribution in Mouse Brain via MALDI-2 Mass Spectrometry Imaging 63
Design, Synthesis and In Vitro Experimental Validation of Novel TRPV4 Antagonists Inspired by Labdane Diterpenes 63
Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin 63
NAAA is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth 62
TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β-catenin signalling 62
Identification and characterization of cannabidiol as an ox1r antagonist by computational and in vitro functional validation 62
The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation. 62
First separation of commendamide enantiomers 61
Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer’s disease 61
Life-long epigenetic programming of cortical architecture by maternal 'Western' diet during pregnancy 61
Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat 61
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling 61
The sleep inducing factor oleamide is produced by mouse neuroblastoma cells 61
Nanoparticle-mediated cellular uptake-controlled release as a tool to study anandamide membrane transport 60
Endocannabinoids Part I: Molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors 60
Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system 60
Method for treating pain 1831Prov1 59
Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats 59
Potential use of cannabimimetics in the treatment of cancer 59
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects 59
Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo 59
Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study 59
Ultra-micronized palmitoylethanolamide rescues the cognitive decline-associated loss of neural plasticity in the neuropathic mouse entorhinal cortex-dentate gyrus pathway 59
'Endocannabinoids', endogenous phospholipid-derived metabolites with cannabimimetic properties: biosynthesis and catabolism 58
Indole-2-carboxamides as allosteric modulators of the cannabinoid CB1 receptor. 58
Manipulation of dietary amino acids prevents and reverses obesity in mice through multiple mechanisms that modulate energy homeostasis 58
1.Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis. 58
Totale 7.186
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.200
article - articoli 95.545
book - libri 280
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.247
Totale 222.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024237 0 0 0 0 0 0 0 0 12 31 70 124
2024/20259.827 57 62 875 575 1.139 145 52 342 273 325 3.098 2.884
2025/202618.917 912 1.720 1.973 2.903 3.201 596 3.034 1.119 1.167 882 733 677
2026/20274.049 971 1.180 1.898 0 0 0 0 0 0 0 0 0
Totale 33.030